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ORIGINAL ARTICLE
Mapping Trachoma in the Solomon Islands: Results of Three Baseline
Population-Based Prevalence Surveys Conducted with the Global Trachoma
Mapping Project
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Claude Posalaa, and Anthony W. Solomonb, for the Global Trachoma Mapping Project*
aEyecare Department, Ministry of Health, Honiara, Solomon Islands; bClinical Research Department, London School of Hygiene & Tropical Medicine,
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ABSTRACT
Purpose: We sought to complete the baseline trachoma map of the Solomon Islands by establish-
ing prevalences of active trachoma and trichiasis in the provinces of Choiseul, Western, Rennell-
Bellona, and Temotu.
Methods: Using the standardized methodology developed for the Global Trachoma Mapping
Project, we conducted cross-sectional community-based surveys from September to November
2013. Choiseul and Western provinces were each mapped as separate evaluation units (EUs);
Rennell-Bellona and Temotu were combined to form a third EU.
Results: A total of 9819 individuals were sampled for inclusion, with 9224 (93.3%) consenting to
examination, of whom 4587 (46.3%) were female. Survey teams visited 82 villages, and surveyed
2448 households. Two EUs had prevalences of trachomatous inflammation – follicular (TF) in 1–9-
year-olds over the 10% threshold at which WHO recommends mass distribution of azithromycin
for at least 3 years (Western 20.4%, 95% confidence interval, CI 15.6–26.3%; Rennell-Bellona/
Temotu 22.0%, 95% CI 18.5–26.0%). Choiseul had a TF prevalence of 6.1% (95% CI 4.1–8.6%), and
met the criterion for a single round of mass antibiotic distribution before re-survey. The adjusted
prevalences of trichiasis in those aged 15+ years were 0.0% (95% CI 0.0–0.2%) in Choiseul, 0.16%
(95% CI 0.0–0.5%) in Western, and 0.10% (95% CI 0–0.3%) in Rennell-Bellona/Temotu provinces. All
three EUs require implementation of the facial cleanliness and environmental improvement
components of the trachoma elimination strategy.
Conclusion: Active trachoma is prevalent in the Solomon Islands. However, there is little evidence
of the blinding complications of trachoma being a public health problem there. Further research
into the explanation for this phenomenon is warranted.
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Introduction
The World Health Organization (WHO) estimates
that more than 50 countries are endemic for tra-
choma, the most common infectious cause of blind-
ness worldwide, responsible for visual impairment in
an estimated 1.9 million people.1 In endemic commu-
nities, Chlamydia trachomatis serotypes A–C circulate
among young children causing self-limiting conjunc-
tival infections that decrease in duration with age.2
Trachomatous inflammation – follicular (TF) and tra-
chomatous inflammation – intense (TI) are clinical
manifestations of infection. Repeat inflammatory epi-
sodes may lead to accumulation of scar tissue, which
can distort the eyelids and cause eyelashes to abrade
the eye; when this occurs, it is known as trachomatous
trichiasis (TT). This may lead to corneal opacification
and blindness in severe cases.3 Several systems have
been used to describe this complex, multistage pro-
cess, however, a simplified grading system is the pub-
lic health tool of choice for describing trachoma
phenotypes.4
To eliminate trachoma, the WHO have endorsed the
SAFE strategy (surgery, mass antibiotic treatment, pro-
motion of facial cleanliness and environmental improve-
ment), implemented in a stratified manner based on the
population-level prevalence of clinical signs of disease.
Trachoma is considered to be a public health problem if
the prevalence of unmanaged TT is >0.2% of the popula-
tion aged 15 years and older, or if the prevalence of TF is
≥5% in those aged 1–9 years.5,6
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The Solomon Islands is an archipelago of almost 1000
volcanic islands and coral atolls, with a population of
approximately 520,000 inhabitants, spread over
28,400km2 of the South Pacific Ocean and the Solomon
Sea.7 A number of small, school- or hospital-based studies
in the early 20th century indicated that cases of trachoma
were present across the archipelago,8 however, no sys-
tematic investigation was carried out until a trachoma
rapid assessment in 2007. Cases of TF, trachomatous
scarring and TT were found in a targeted assessment of
high-risk communities in three provinces of the country.9
In 2012, the International Agency for the Prevention of
Blindness commissioned population-based prevalence
surveys in five provinces, the results of which indicated
a high prevalence of TF in those aged 1–9 years (mean
prevalence 18.7%, range 12.0–24.3%) and some cases of
TT in those aged 15 years and older (mean prevalence
across three provinces 0.1%, range 0.0–0.3%). Data also
indicate trachoma endemicity in neighboring Kiribati,
Fiji, and Vanuatu.10–11 Prior to the present study, no
prevalence data existed for Choiseul, Western, Temotu
or Rennell and Bellona provinces of the Solomon Islands,
whose combined population comprises approximately a
quarter of the nation’s population.7 Complete geographi-
cal survey coverage of the country was needed to under-
stand the burden of trachoma, and the level of priority for
intervention.12
The Global Trachoma Mapping Project (GTMP)12
aimed to complete the baseline map of trachoma glob-
ally in over 30 countries using standardized methodol-
ogies, allowing interventions to be directed to those in
need. We conducted GTMP-supported surveys to com-
plete the national map of trachoma in the remaining
four unmapped provinces of the Solomon Islands.
Materials and methods
The surveys used the GTMP methodology described
elsewhere.12 The four provinces were mapped as three
evaluation units (EUs): Choiseul (26,732 inhabitants),
Western (76,649), and Rennell and Bellona plus
Temotu (24,403).7 Based on the latest census data,7 we
estimated a mean of 1.47 children aged 1–9 years per
household. To see 30 households per village, and achieve
a sample size of 1222 children, 1222/(30×1.47) = 27.7
villages should be surveyed. Therefore, we planned to
survey 28 clusters per EU. Fieldwork was undertaken
from 6 September to 21 November 2013.
For each island within an EU, the number of clusters
sampled was assigned in proportion to the population of
the island. Thereafter, villages were sampled from a stan-
dard census list with a probability proportion to size meth-
odology, providing self-weighting of results. On the day of
the survey, village leaders were engaged to create a com-
prehensive list of households, from which 30 households
were randomly sampled by drawing lots. All inhabitants of
these households who were at least 1 year of age were
considered eligible for inclusion. Demographic data were
collected from study participants and a standardized exam-
ination was conducted by GTMP-certified graders12 to
look for trichiasis, TF and TI. Verbal consent was obtained
from the head of the household, from each participating
adult, and from parents or guardians on behalf of the
children in their care. In addition, verbal assent was
obtained from those under 18 years of age. The study was
approved by the Solomon Islands National Health
Research Ethics Committee and the Ethics Committee of
the London School of Hygiene & Tropical Medicine
(6319).
Water, sanitation and hygiene (WASH) variables
Recorders were trained to collect household-level
WASH variables linked to WHO/UNICEF Joint
Monitoring Programme outcomes.13 Data were col-
lected by carrying out a focused interview with the
head of the household using a standard questionnaire
and direct observation.12 Separate questions were asked
about sources of water drinking and washing faces;
many Pacific Islands households use seawater for per-
sonal hygiene purposes.
Statistical analysis
Adjustment of prevalence results was carried out using
R 3.0.2 (R Foundation for Statistical Computing,
Vienna, Austria14). The overall EU-level adjusted TF
prevalence was calculated by adjusting the proportion
of children with TF in each cluster in 1-year age groups
using 2009 Solomon Islands census data,7 then deter-
mining the mean of all such cluster-level proportions.
The same method was used to calculate the overall
adjusted trichiasis prevalence, but with adjustment for
both sex and age in 5-year age groups.12 Confidence
intervals (CIs) around the prevalence estimates were
calculated by bootstrapping the cluster means over
10,000 iterations and taking the 2.5th and 97.5th cen-
tiles of all ordered results.15 Risk factor analysis was
carried out in Stata 10.2 (Stata Corp, College Station,
TX, USA). A 2-level hierarchical model was used with
adjustment for clustering at village and household
levels. Univariable associations were considered for
inclusion in the multivariable model if p ≤ 0.05
(Wald’s test).
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Results
A total of 82 villages were surveyed over three EUs. The
coordinates of sampled villages are shown in Figure 1. A
total of 2448 households were visited, 9891 inhabitants
were eligible to participate in the study, of whom 9224
individuals (93.3%) consented to examination and were
examined. Overall, 25 villages were sampled in Choiseul,
25 in Western, and 32 in Rennell-Bellona/Temotu. The
number of villages was increased in Rennell-Bellona/
Temotu due to low numbers of children found in the
villages first sampled. The demographics of those
sampled are shown in Table 1.
Prevalences of TF in children aged 1–9 years (Figure 2,
Table 2) and prevalences of trichiasis in adults (Figure 3,
Table 3) are shown by EU. A total of eight cases of
trichiasis were found in the survey; six of these cases
were found in Western province, and two in Rennell-
Bellona/Temotu. The age- and sex-adjusted trichiasis pre-
valences in those aged 15+ years were 0.0% in Choiseul,
0.16% in Western, and 0.1% in Rennell-Bellona/Temotu.
WASH data
WASH data were obtained from 2448 households.
Practicing open defecation was reported by adults in
1443 households (58.9%), with the most common site
of defecation being in the sea or on the beach. Only
1006 households (41.1%) reported using some kind of
latrine: 302 houses (12.3%) had an improved latrine, of
which 260 were private latrines, and 704 (28.8%)
households had an unimproved latrine. Overall, 1443
houses (58.9%) had access to improved washing water
Figure 1. Coordinates of villages sampled in the three evaluation units surveyed, Global Trachoma Mapping Project, Solomon
Islands, September–November 2013, and trachomatous inflammation – follicular (TF) prevalence estimates in five other provinces.10
Shapefile source: Global administrative areas (gadm.org).
Table 1. Sampled population, Global Trachoma Mapping Project, Solomon Islands, September–November
2013.
Province
Choiseul Western Rennell-Bellona/Temotu Total
Sampled, n 2709 3129 4053 9891
Examined, n (%) 2634 (97.2) 2914 (93.1) 3676 (90.7) 9224 (93.3)
Absent, n (%) 56 (2.1) 213 (6.8) 340 (8.4) 609 (6.2)
Refused, n (%) 19 (0.7) 2 (0.1) 36 (0.9) 57 (0.6)
Age, median years (range) 17 (1–99) 17 (1–95) 19 (1–100) 18 (1–100)
Female, n (%) 1165 (43.0) 1458 (46.6) 1964 (48.5) 4587 (46.3)
Households, n 742 751 955 2448
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and 1595 households (65.1%) had improved drinking
water. In the univariate logistic regression analysis, no
household level WASH variables were associated with
the presence of TF in 1–9-year-old children. The full
results are shown in Table 4.
Discussion
The prevalence of active trachoma was above 5% in
each EU, and above 10% in two of the three EUs
(three of four provinces) studied. WHO guidelines
recommend implementation of the A, F and E com-
ponents of SAFE, including mass administration of
azithromycin, in Western and Rennell-Bellona/
Temotu provinces, for at least 3 years before impact
surveys are done. However, the prevalence of trichia-
sis in each province was low, and below the level
established by WHO as being indicative of a public
health problem in all three EUs. This is consistent
with the experience of ophthalmologists in the
Solomon Islands, who see cases of trichiasis in their
clinics very rarely.9,16 This raises the question of
whether trachoma can truly be thought to be a sig-
nificant public health problem in these populations.
Trachoma surveys from endemic countries of Sub-
Saharan Africa, such as Ethiopia or Nigeria, report
much higher prevalences of trichiasis in districts
with prevalent TF. It is therefore unclear why, even
in the presence of a high prevalence of active tra-
choma in children, the blinding effects of trachoma
are rarely seen in adults in the Solomon Islands. A
similar question is raised by corresponding GTMP
data from other countries in the South Pacific.17
The anomaly could be attributable to a different set
of C. trachomatis genotypes in the region, a different
bacterium altogether being responsible for the active
trachoma phenotype, or a more muted scarring
response of those infected.18–20
Recent studies on causes of blindness in the Solomon
Islands are scarce. Reports from the Fred Hollows
Figure 2. Trachomatous inflammation – follicular (TF) prevalence in children aged 1–9 years, Global Trachoma Mapping Project,
Solomon Islands, September–November 2013. Shapefile source: Global administrative areas (gadm.org).
Table 2. Prevalence of trachomatous inflammation – follicular
(TF) in children aged 1–9 years, Global Trachoma Mapping
Project, Solomon Islands, September–November 2013.
Evaluation unit Examined, n TF, n (%)
Adjusteda TF, %
(95% CI)
Choiseul 881 66 (7.5) 6.1 (4.1–8.6)
Western 996 226 (22.7) 20.4 (15.6–26.3)
Rennell-Bellona/Temotu 1136 296 (26.1) 22.0 (18.5–26.0)
aAdjusted by age in 1-year bands.
CI, confidence interval.
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Foundation eye health outreach services describe 10 cases
of trichiasis identified in the Solomon Islands between 2011
and 2013.16 These reports suggest cataract is the dominant
cause of blindness in the country, and do not suggest a
major burden of trachoma. While the clinical snapshot
obtained from the current surveys indicates a low preva-
lence of trachoma’s blinding sequelae, it is not currently
clear whether prevalence is changing over time; trachoma
could be in a period of increase, stasis or decline.
Trachoma has been linked with low levels of access to
sanitation.21 The availability of sanitation found in this
study was very low. Adults in a high proportion of house-
holds (58.9%) practiced open defecation, yet children from
these homes were no more likely to have TF than those
from households with the best sanitation access. None of
the WASH variables collected were associated with TF in
children. This is not too surprising; although the disease is
almost exclusively associated with rural areas of poverty
and social deprivation, there is some inconsistency in
WASH associations and no universal risk factors for tra-
choma. For example, it has previously been associated with
poor access to water,22–26 but clear exceptions exist.27–29
The inhabitants of this diverse group of islands are
separated from each other not just geographically, but
also culturally and ethnically. It is possible that parti-
cular behaviors associated with these cultures could in
part explain the differences in trachoma prevalence
between EUs, and help to inform appropriate control
strategies, but these considerations were not examined
in this set of surveys.
Based on our results, current WHO guidelines
would indicate that azithromycin mass drug adminis-
tration is needed in all three EUs. Azithromycin dis-
tribution would have the added benefit of treating
yaws30 and may also treat urogenital C. trachomatis,31
both of which are highly prevalent locally.32,33
Table 3. Prevalence of trichiasis in those aged 15 years or older, Global Trachoma Mapping Project, Solomon Islands, September–November
2013.
Evaluation unit
Examined, n (%) Trichiasis, n (%)
Adjusteda trichiasis, % (95% CI)Male Female Male Female
Choiseul 533 (36.9) 913 (63.1) 0 (0.0) 0 (0.0) 0.0 (0.0–0.2)
Western 712 (42.4) 967 (57.6) 3 (0.4) 3 (0.3) 0.16 (0.0–0.5)
Rennell-Bellona/Temotu 1064 (45.5) 1275 (54.5) 0 (0.0) 2 (0.2) 0.04 (0.0–0.3)
aAdjusted for sex and age in 5-year bands.
CI, confidence interval.
Figure 3. Trichiasis prevalence in those aged 15 years and older, Global Trachoma Mapping Project, Solomon Islands, September–
November 2013. Shapefile source: Global administrative areas (gadm.org).
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However, given the paucity of data showing blinding
complications of trachoma here, there is also an obliga-
tion to undertake intensive basic and operational
research into the etiology of, and the effect of SAFE
implementation on, the active trachoma phenotype in
these populations.
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